Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunometabolic Pattern of Intermittent Hypoxia as a Protective Mechanism Against Lethal Reperfusion Injury in Patients With ST-segment Elevation Myocardial Infarction

NCT05230966 is registered in ClinicalTrials.gov with Clinical Hospital Center Rijeka as lead sponsor.

NCT NCT05230966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05230966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunometabolic Pattern of Intermittent Hypoxia as a Protective Mechanism Against Lethal Reperfusion Injury in Patients With ST-segment Elevation Myocardial Infarction
Lead sponsor
Clinical Hospital Center Rijeka
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
March 2, 2023
Enrollment
25 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial ischemic-reperfusion injury